Global Information
회사소개 | 문의 | 비교리스트

만성 피부 홍반성 루푸스(CCLE) 및 원판상 홍반성 루푸스(DLE) : 세계 임상시험 리뷰

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019

리서치사 GlobalData
발행일 2019년 04월 상품 코드 318330
페이지 정보 영문 65 Pages
가격
US $ 2,500 ₩ 3,017,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,035,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 9,052,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


만성 피부 홍반성 루푸스(CCLE) 및 원판상 홍반성 루푸스(DLE) : 세계 임상시험 리뷰 Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019
발행일 : 2019년 04월 페이지 정보 : 영문 65 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

만성 피부 홍반성 루푸스(CCLE) 및 원판상 홍반성 루푸스(DLE)의 임상시험 관련 기본 정보 및 데이터, 시험건수 및 피험자 모집 상황, 단계별 동향, 임상시험을 시행하고 있는 주요 제약기업 및 연구기관의 개요 등을 정리하여 전해드립니다.

서론

  • 만성 피부 홍반성 루푸스(CCLE) 및 원판상 홍반성 루푸스(DLE)
  • 본 보고서 개요

각 지역의 임상시험 상황

  • 각국의 임상시험 건수와 평균 피험자수
    • 유럽 주요 국가의 임상시험 건수
    • 북미 주요 국가의 임상시험 건수
    • 중동·아프리카 주요 국가의 임상시험 건수

G7 국가에서의 임상시험 건수 : 면역질환 치료제 임상시험에서 만성 피부 홍반성 루푸스(CCLE) 및 원판상 홍반성 루푸스(DLE)의 비율

G7 국가의 단계별 임상시험 건수

G7 국가에서의 임상시험 건수 : 진척 상황별

단계별 임상시험 건수

  • 진행중인 임상시험 : 단계별

진척 상황별 임상시험 건수

임상시험의 목표 달성 상황

미완료 임상시험 건수

일정기간 채용된 피험자

스폰서 종류별 임상시험 건수

유망 스폰서

만성 피부 홍반성 루푸스(CCLE) 및 원판상 홍반성 루푸스(DLE) 치료제 임상시험에 종사하고 있는 주요 기업

유망 약제

임상시험 개요

  • 주요 기업의 임상시험 개요
    • Celgene Corporation
    • Astion Pharma A/S
    • Amgen Inc.
    • Rigel Pharmaceuticals, Inc.
    • Immunomedics, Inc.
  • 대표적인 연구기관·병원의 임상시험 개요
    • Department of Health, South Africa
    • Florida Academic Dermatology Centers
    • The Newcastle upon Tyne Hospitals NHS Foundation Trust
    • Shahid Beheshti University of Medical Sciences
    • The Cleveland Clinic
    • Wake Forest University
    • New York University School of Medicine
    • National Cancer Institute
    • University of Leipzig

5개의 대표적인 임상시험 개요

부록

KSA 14.11.26

List of Tables

  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Region, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Central and South America, Top Countries, 2019*
  • Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, G7 Countries (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, E7 Countries (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures

  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019*
  • Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, G7 Countries (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, E7 Countries (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • GlobalData Methodology

GlobalData's clinical trial report, "Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables
  • List of Figures
  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source
Back to Top
전화 문의
F A Q